Patents
Orchid licenses key pharmacogenomics patent
Published in Gene Therapy Weekly, August 1st, 2002
Under the terms of the agreement, Orchid obtains rights to market cytochrome P450 2D6 (CYP2D6) testing services in North America. Orchid intends to offer CYP2D6 testing as part of the initial pharmacogenomics panel soon to enter beta testing under the aegis of its Orchid GeneShield unit, as well as in value-added genotyping products and services provided by its Orchid Life Sciences unit.
Financial details of the agreement were not disclosed.
"Our...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2002-08-01)
More Articles from Gene Therapy Weekly
- Bioengineering
Microparticles useful vectors for controlled release of synthesized DNA - Liver Disease Therapy
Drug delivery to the liver could be increased with peptide transporter - Breast Cancer Therapy
Interferon and endostatin gene therapy outpace angiostatin in breast cancers - Renal Cancer
Antisense molecules can delay renal carcinoma growth in murine models - Type 1 Diabetes
Pharmacological regulation allows liver cells to produce insulin on demand - Cancer Therapies
Phase I study: Single dose of Introgen's INGN 241 kills up to 70% of tumor cells via apoptosis - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
